Transit Scientific Announces the Close of Its Series A financing Round
The company achieved FDA clearances and multi-center, multi-user, safe-patient-use of its XO Score angioplasty scoring-cutting platform and separate XO Cross 0.014" and 0.035" microcatheter platform in late 2020.